Endovascular treatment versus femoropopliteal bypass surgery for TASC II type C lesions of the superficial femoral artery
Onur Saydam, Deniz Serefli, Mehmet Atay, Aysen Yaprak Engin
DOI: 10.9739/tjvs.2022.1067 · Page: 25-32 · 124 Views · 6 Downloads · 2 Citations
Abstract
Results: The primary success rates for ET and FPB were 100%. Primary patency at 6, 12, and 24 months were 93.5%, 89.0%, 69.5%, respectively for ET and 86.4%, 81.5%, 72.8%, respectively for FPB (p>0.05). Secondary patency rates at 6, 12, and 24 months were 97.8%, 93.5%, %84.8, respectively for ET and 96.1%, 90.3%, 79.6%, respectively for FPB group (p=0.41). The length of hospital stay was significantly longer in the FPB group (p<0.001). The cost of treatment was significantly higher in the FBP group (p=0.02).
Conclusion: In TASC II type C patients, ET is a safe therapeutic option with lower in-hospital stay and treatment expenses and similar primary and secondary patency rates to FPB.Keywords : Atherosclerosis, balloon angioplasty, endovascular procedures, femoropopliteal bypass, peripheral artery disease
Keywords : Atherosclerosis; balloon angioplasty; endovascular procedures; femoropopliteal bypass; peripheral artery disease